4886.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan...

Stats
Объем за сегодня	45 100.00
Средний объем	66 082.00
Рыночная капитализация	64.02B
EPS	¥0 ( 2024-02-04 )
Дата следующего отчета о доходах	( ¥0 ) 2024-05-10
Last Dividend	¥8.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	9.82
ATR14	¥1.668 (0.07%)

Объем Корреляция

Длинно: 0.05 (neutral)

Кратко: -0.72 (moderate negative)

Signal:(38.949) Neutral

ASKA Pharmaceutical Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

ASKA Pharmaceutical Корреляция - Валюта/Сырье

-0.51
( weak negative )

-0.30
( neutral )

0.78
( moderate )

-0.52
( weak negative )

-0.34
( neutral )

0.69
( moderate )

ASKA Pharmaceutical Финансовые показатели

Annual	2022
Выручка:	¥60.46B
Валовая прибыль:	¥28.59B (47.28 %)
EPS:	¥150.08

FY	2022
Выручка:	¥60.46B
Валовая прибыль:	¥28.59B (47.28 %)
EPS:	¥150.08

FY	2022
Выручка:	¥56.61B
Валовая прибыль:	¥26.35B (46.55 %)
EPS:	¥151.22

Financial Reports:

No articles found.

ASKA Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥8.00 (N/A)	¥0 (N/A)	¥8.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

ASKA Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.89 - Decrease likely (22.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥7.00	2021-09-29
Last Dividend	¥8.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	¥31.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.89
Div. Directional Score	7.56	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

3.32

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8291.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
7685.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
6857.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6218.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4951.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4112.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3321.T	Ex Dividend Knight	2023-11-29	Semi-Annually	0.00%
2395.T	Ex Dividend Junior	2023-09-28	Sporadic	0.00%
9322.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8050.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.105	1.500	7.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0687	1.200	7.71	9.25	[0 - 0.3]
returnOnEquityTTM	0.113	1.500	9.85	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.88	0.800	0.604	0.483	[1 - 3]
quickRatioTTM	1.797	0.800	4.14	3.31	[0.8 - 2.5]
cashRatioTTM	0.811	1.500	6.61	9.91	[0.2 - 2]
debtRatioTTM	0.107	-1.500	8.22	-10.00	[0 - 0.6]
interestCoverageTTM	130.07	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.167	-1.500	9.33	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.481	1.000	5.31	5.31	[0.2 - 0.8]
operatingProfitMarginTTM	0.0902	1.000	-0.197	-0.197	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.574	1.000	7.92	7.92	[0.2 - 2]
assetTurnoverTTM	0.654	0.800	8.97	7.18	[0.5 - 2]
Total Score				11.22

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	9.83	1.000	9.11	0	[1 - 100]
returnOnEquityTTM	0.113	2.50	9.91	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.770	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	204.81	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-13.04	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0935	1.000	-0.161	0	[0.1 - 0.5]
Total Score				3.89

ASKA Pharmaceutical

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.